Branislav Radović
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Branislav Radović has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Nemanja Vujic
Gottfried Schatz Research Center, Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria
4 shared publications - Dagmar Kratky
Gottfried Schatz Research Center, Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria
3 shared publications Madeleine Goeritzer
Gottfried Schatz Research Center, Medical University of Graz, Graz, Austria
3 shared publicationsDagmar Kolb
Center for Medical Research/Institute of Cell Biology, Histology and Embryology, Medical University of Graz, Harrachgasse 21, 8010 Graz, Austria
2 shared publications- Prakash Doddapattar
Division of Hematology/Oncology, Department of Internal Medicine (R.B.P., N.D., B.S., M.G., P.D., T.B., M.K., A.K.C.), University of Iowa, Iowa City
2 shared publications Prakash G. Chandak
Institute of Molecular Biology & Biochemistry, Center of Molecular Medicine, Medical University of Graz, Harrachgasse 21, 8010 Graz, Austria
2 shared publications
Latest Publications
- Open Access
Impaired Bile Acid Metabolism and Gut Dysbiosis in Mice Lacking Lysosomal Acid Lipase
Lysosomal acid lipase (LAL) is the sole enzyme known to be responsible for the hydrolysis of cholesteryl esters and triglycerides at an acidic pH in lysosomes, resulting in the release of unesterified cholesterol and free fatty acids. However, the role of LAL in diet-induced adaptations is largely unexplored. In this study, we demonstrate that feeding a Western-type diet to Lal-deficient (LAL-KO) mice triggers metabolic reprogramming that modulates gut-liver cholesterol homeostasis. Induction of ileal fibroblast growth factor 15 (three-fold), absence of hepatic cholesterol 7α-hydroxylase expression, and activation of the ERK phosphorylation cascade results in altered bile acid composition, substantial changes in the gut microbiome, reduced nutrient absorption by 40%, and two-fold increased fecal lipid excretion in LAL-KO mice. These metabolic adaptations lead to impaired bile acid synthesis, lipoprotein uptake, and cholesterol absorption and ultimately to the resistance of LAL-KO mice to diet-induced obesity. Our results indicate that LAL-derived lipolytic products might be important metabolic effectors in the maintenance of whole-body lipid homeostasis.
Open AccessImpaired Bile Acid Metabolism and Gut Dysbiosis in Mice Lacking Lysosomal Acid Lipase
Lysosomal acid lipase (LAL) is the sole enzyme known to be responsible for the hydrolysis of cholesteryl esters and triglycerides at an acidic pH in lysosomes, resulting in the release of unesterified cholesterol and free fatty acids. However, the role of LAL in diet-induced adaptations is largely unexplored. In this study, we demonstrate that feeding a Western-type diet to Lal-deficient (LAL-KO) mice triggers metabolic reprogramming that modulates gut-liver cholesterol homeostasis. Induction of ileal fibroblast growth factor 15 (three-fold), absence of hepatic cholesterol 7α-hydroxylase expression, and activation of the ERK phosphorylation cascade results in altered bile acid composition, substantial changes in the gut microbiome, reduced nutrient absorption by 40%, and two-fold increased fecal lipid excretion in LAL-KO mice. These metabolic adaptations lead to impaired bile acid synthesis, lipoprotein uptake, and cholesterol absorption and ultimately to the resistance of LAL-KO mice to diet-induced obesity. Our results indicate that LAL-derived lipolytic products might be important metabolic effectors in the maintenance of whole-body lipid homeostasis.
- Open Access
- 18 January 2021
- Published by Taylor & Francis in Autophagy
- Vol. 17 (11) , 3402-3407
ATG7 is dispensable for LC3–PE conjugation in thioglycolate-elicited mouse peritoneal macrophages
Thioglycolate-elicited macrophages exhibit abundant conjugation of LC3 with PE (LC3-II). Among other autophagy-related (ATG) proteins, it is proposed that, like in yeast, both ATG5 and ATG7 are essential for LC3 conjugation. Using atg5-deficient (−/-) and atg7−/-macrophages, we provide evidence that loss of ATG5 but not of ATG7 resulted in LC3-II depletion. Accumulation of LC3-II in elicited atg7−/- macrophages in response to bafilomycin A1 validated these data. Furthermore, complete loss of ATG3 in atg7−/- macrophages demonstrated that ATG7 and ATG3 are dispensable for LC3–PE conjugation. In contrast to thioglycolate-elicited macrophages, naïve peritoneal and bone marrow-derived atg7−/- macrophages exhibited no LC3-II, even under inflammatory stimuli in vitro. Hence, the macrophage metabolic status dictates the level of LC3–PE conjugation with a supportive but nonessential role of ATG7, disclosing the eukaryotic exception from the LC3 lipidation model based on yeast data. Abbreviations: ATG: autophagy-related; BM: bone marrow; MAP1LC3/LC3: microtubule-associated protein 1 light chain 3; PE: phosphatidylethanolamine.
- 18 January 2021
- Published by Taylor & Francis in Autophagy
- Vol. 17 (11) , 3402-3407
Open AccessATG7 is dispensable for LC3–PE conjugation in thioglycolate-elicited mouse peritoneal macrophages
Thioglycolate-elicited macrophages exhibit abundant conjugation of LC3 with PE (LC3-II). Among other autophagy-related (ATG) proteins, it is proposed that, like in yeast, both ATG5 and ATG7 are essential for LC3 conjugation. Using atg5-deficient (−/-) and atg7−/-macrophages, we provide evidence that loss of ATG5 but not of ATG7 resulted in LC3-II depletion. Accumulation of LC3-II in elicited atg7−/- macrophages in response to bafilomycin A1 validated these data. Furthermore, complete loss of ATG3 in atg7−/- macrophages demonstrated that ATG7 and ATG3 are dispensable for LC3–PE conjugation. In contrast to thioglycolate-elicited macrophages, naïve peritoneal and bone marrow-derived atg7−/- macrophages exhibited no LC3-II, even under inflammatory stimuli in vitro. Hence, the macrophage metabolic status dictates the level of LC3–PE conjugation with a supportive but nonessential role of ATG7, disclosing the eukaryotic exception from the LC3 lipidation model based on yeast data. Abbreviations: ATG: autophagy-related; BM: bone marrow; MAP1LC3/LC3: microtubule-associated protein 1 light chain 3; PE: phosphatidylethanolamine.
- Open Access
- 1 October 2015
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1851 (10) , 1304-1316
Active autophagy but not lipophagy in macrophages with defective lipolysis
- 1 October 2015
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1851 (10) , 1304-1316
Open AccessActive autophagy but not lipophagy in macrophages with defective lipolysis
- Open Access
- 3 May 2013
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 57 (10) , 1718-1728
Xanthohumol ameliorates atherosclerotic plaque formation, hypercholesterolemia, and hepatic steatosis in ApoE‐deficient mice
Scope: Xanthohumol (XN), a prenylated antioxidative and anti‐inflammatory chalcone from hops, exhibits positive effects on lipid and glucose metabolism. Based on its favorable biological properties, we investigated whether XN attenuates atherosclerosis in western‐type diet‐fed apolipoprotein‐E‐deficient (ApoE−/−) mice.Methods and results: XN supplementation markedly reduced plasma cholesterol concentrations, decreased atherosclerotic lesion area, and attenuated plasma concentrations of the proinflammatory cytokine monocyte chemoattractant protein 1. Decreased hepatic triglyceride and cholesterol content, activation of AMP‐activated protein kinase, phosphorylation and inactivation of acetyl‐CoA carboxylase, and reduced expression levels of mature sterol regulatory element‐binding protein (SREBP)‐2 and SREBP‐1c mRNA indicate reduced lipogenesis in the liver of XN‐fed ApoE−/− mice. Concomitant induction of hepatic mRNA expression of carnitine palmitoyltransferase‐1a in ApoE−/− mice‐administered XN suggests increased fatty acid beta‐oxidation. Fecal cholesterol concentrations were also markedly increased in XN‐fed ApoE−/− mice compared with mice fed western‐type diet alone.Conclusion: The atheroprotective effects of XN might be attributed to combined beneficial effects on plasma cholesterol and monocyte chemoattractant protein 1 concentrations and hepatic lipid metabolism via activation of AMP‐activated protein kinase.
- 3 May 2013
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 57 (10) , 1718-1728
Open AccessXanthohumol ameliorates atherosclerotic plaque formation, hypercholesterolemia, and hepatic steatosis in ApoE‐deficient mice
Scope: Xanthohumol (XN), a prenylated antioxidative and anti‐inflammatory chalcone from hops, exhibits positive effects on lipid and glucose metabolism. Based on its favorable biological properties, we investigated whether XN attenuates atherosclerosis in western‐type diet‐fed apolipoprotein‐E‐deficient (ApoE−/−) mice.Methods and results: XN supplementation markedly reduced plasma cholesterol concentrations, decreased atherosclerotic lesion area, and attenuated plasma concentrations of the proinflammatory cytokine monocyte chemoattractant protein 1. Decreased hepatic triglyceride and cholesterol content, activation of AMP‐activated protein kinase, phosphorylation and inactivation of acetyl‐CoA carboxylase, and reduced expression levels of mature sterol regulatory element‐binding protein (SREBP)‐2 and SREBP‐1c mRNA indicate reduced lipogenesis in the liver of XN‐fed ApoE−/− mice. Concomitant induction of hepatic mRNA expression of carnitine palmitoyltransferase‐1a in ApoE−/− mice‐administered XN suggests increased fatty acid beta‐oxidation. Fecal cholesterol concentrations were also markedly increased in XN‐fed ApoE−/− mice compared with mice fed western‐type diet alone.Conclusion: The atheroprotective effects of XN might be attributed to combined beneficial effects on plasma cholesterol and monocyte chemoattractant protein 1 concentrations and hepatic lipid metabolism via activation of AMP‐activated protein kinase.
- 22 July 2010
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 54 (S2) , S225-S235
Xanthohumol, a prenylated chalcone from hops, modulates hepatic expression of genes involved in thyroid hormone distribution and metabolism
In the present study, we analyzed the influence of xanthohumol (XN) on thyroid hormone (TH) distribution and metabolism in rats. A potent and selective competition of XN for thyroxine (T4) binding to transthyretin (IC50=1 μM at 1.7 nM [125I]T4) was found in human and rat sera in vitro. Female rats treated orally with XN showed increased hepatic expression of T4‐binding globulin and decreased transthyretin and albumin. Thyrotropin levels and hepatic type 1 deiodinase activity were moderately increased. Northern blot analysis revealed diminished expression of liver sulfotransferase (Sult1a1) and uridine‐diphosphate glucuronosyltransferase (Ugt1a1) after XN treatment. The transcript levels of constitutive androstane receptor (CAR), known to be involved in regulation of enzymes metabolizing hormones, drugs and xenobiotics, was lower in rats treated with >10 mg XN/kg body weight per day. Immunoblot analysis indicates reduced amounts of CAR protein. The phenobarbital‐inducible cytochrome P450 mRNA level was decreased in rats treated with >10 mg XN/kg/day, in agreement with reduced CAR protein. Although only moderate changes in TH serum levels were observed, the XN‐dependent altered expression of components involved in TH homeostasis might be important not only for hormone metabolism, but also for hepatic phase I and II elimination of drug metabolites and xenobiotics.
- 22 July 2010
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 54 (S2) , S225-S235
Xanthohumol, a prenylated chalcone from hops, modulates hepatic expression of genes involved in thyroid hormone distribution and metabolism
In the present study, we analyzed the influence of xanthohumol (XN) on thyroid hormone (TH) distribution and metabolism in rats. A potent and selective competition of XN for thyroxine (T4) binding to transthyretin (IC50=1 μM at 1.7 nM [125I]T4) was found in human and rat sera in vitro. Female rats treated orally with XN showed increased hepatic expression of T4‐binding globulin and decreased transthyretin and albumin. Thyrotropin levels and hepatic type 1 deiodinase activity were moderately increased. Northern blot analysis revealed diminished expression of liver sulfotransferase (Sult1a1) and uridine‐diphosphate glucuronosyltransferase (Ugt1a1) after XN treatment. The transcript levels of constitutive androstane receptor (CAR), known to be involved in regulation of enzymes metabolizing hormones, drugs and xenobiotics, was lower in rats treated with >10 mg XN/kg body weight per day. Immunoblot analysis indicates reduced amounts of CAR protein. The phenobarbital‐inducible cytochrome P450 mRNA level was decreased in rats treated with >10 mg XN/kg/day, in agreement with reduced CAR protein. Although only moderate changes in TH serum levels were observed, the XN‐dependent altered expression of components involved in TH homeostasis might be important not only for hormone metabolism, but also for hepatic phase I and II elimination of drug metabolites and xenobiotics.